• Tailored Light Exposure Improves Sleep, Mood, Behavior in Alzheimer’s Patients, Study Shows
  • ProMIS Working to Move Antibody Treatment for Alzheimer’s into Clinical Trials
  • Potential Alzheimer’s Treatment Targeting Bacteria Seen as Safe in Early Trial, Cortexyme Says
  • Memory Training Tool Using Virtual Reality Available for Alzheimer’s Patients
  • Phase 3 Trials of Lanabecestat in Alzheimer’s Patients Stopped for Lack of Efficacy, Eli Lilly and AstraZeneca Announce
  • Red Sox Support Cure Alzheimer’s Fund, Disease Research at June Game Against Detroit Tigers
  • Alzheimer’s Therapy Elenbecestat Reduces Brain Amyloid Levels, is Safe and Well-Tolerated, Trial Shows
  • Responding to Common Myths About Alzheimer’s Disease
  • Type 2 Diabetes Therapies May Help Relieve Alzheimer’s Symptoms, Researchers Say
  • Cognition Therapeutics Awarded $6.6M to Support 2 Elayta Trials for Alzheimer’s
  • Phase 1 Trial Assessing Stem Cell Therapy Recruiting Alzheimer’s Patients in Florida
  • UsAgainstAlzheimer’s Launches AD PACE, New Patient-Caregiver Initiative